TMU BioMed Accelerator x BE Accelerator’s healthcare demo day has been hosted virtually on July 20th. Nine Taiwanese and international startups pitched their moonshot healthcare solutions in the fields of Digital Health, Medical Devices, and AI Healthcare.
In this "TMU X BE Demo Day", we invited ANDREA HSU, Director of the Ministry of Science and Technology, Dr./Professor Chien-Huang Lin, President of Taipei Medical University, and Arthur Chen, the executive director of BE Accelerator, to celebrate the grand opening of the event. At the same time, we also invited Professionals from various fields participated in this grand event.
Continuing the two-strong joint acceleration program launched in 2020, this year, Taipei Medical University continuously inputs clinical resources from the university and six hospitals, during the acceleration period, TMU BioMed Accelerator initiated the formation of the "Hospital Clinical implementation Committee" and invited Director-level and above decision-making supervisors of Taipei Medical University Hospital, Wanfang Hospital and Shuanghe Hospital, from the perspective of clinical practice of the hospital, discussed face-to-face with the startups in a short period of time, and invited startups to understand the hospital's decision-making and evaluation process, as well as many practical suggestions for cooperation with the hospital, create more opportunities for clinical site with startup’s collaboration.
Apart from that, through BE Accelerator’s professional business counseling and investment evaluation, understands the resources that the startup team needs the most today, and links them with professional mentors in the industry, conducts one-to-one consultations, and gives them the most appropriate feedback and opinions. The startups can quickly solve the problems and accelerate their growth.
This event is also the first time was revealed in a live studio and live broadcasted. Each 9 startups conducted a five-minute pitching and QA through live. With invisible audiences and they could still keep up with the rhythm of the stage and share with the audience about their more than five months acceleration period, with the input of many professional biomedical resources, and how they achieve accelerated business growth.
The goal of this event is not only to show the actual results of coaching, but also to share the upcoming "International Market Expansion Pilot Trial" targeting the United States and Japan, as well inviting our American partner Christine Winoto, Executive Director of UCSF Rosenman Institute , And Japanese partner Yujiro Maeda, Co-director of Japan Biodesign & Co-founder of Premo Partners, share relevant content for startups to have opportunities to connect with medical institutions in San Francisco, USA and Tokyo, Japan!
Here’s a peek at the companies that presented during the July 20 demo day:
UpperMed, a Singapore-based MedTech company which is working on home dialysis remote management service. The team is dedicated to improving the quality of life for dialysis patients.
Meracle Based in Singapore, wants to improve the management of chronic respiratory diseases by increasing the efficiency of medication delivered into the lungs while tracking intake data to optimize the assessment of treatment outcomes
Atgenomix, with a team of data scientists with a single-minded focus on driving innovative computing in clinical genomics, Atgenomix accelerates future life science and helps overwhelmed researchers and clinicians deal with the immense challenges of data deluge in genomics.
SiriuXense builds the “Smart Care Ecosystem for All Ages'' by integrating bioacoustics sensing technology, algorithm, IoT, and a data-driven platform.
LuminX based in Taiwan, is a pharmacokinetic platform for preclinical evaluation of therapeutic cells to transform a potential therapy from the research stage to advanced clinical and commercial applications to save lives.
ezOxygen Spirometer utilizes exclusive passive ultrasonic detection technology to record the sound from the user’s exhalation, transmit to the mobile app and calculate as lung function parameters, provide user managing their own lung health status.
B.D.Mobile is a medical technology company committed to making cardiac diagnostics scalable and accessible to everyone, by creating solutions for clinicians to face the ever-increasing demand for diagnostics.
PROPHET, an AI Bio-maker model using AI technology to screen cancer and provide the prediction.
HomeXin focuses on long-term healthcare, provides hospitalized families comprehensive help services.
[About TMU BioMed Accelerator]
Taiwan's first international medical university accelerator with a perfect
medical marketplace, clinical advantages, biomedical and artificial
intelligence talents, focusing on digital health, artificial intelligence and
medical equipment, assisting start-up to raise funds, community and
international resource linkage, coaching and reducing development
risks, clinical trial planning, establishing medical pathways.
[About BE Accelerator]
BE Accelerator is the largest growth-focused program and venture fund
for healthtech, medtech and digital health startups in Taiwan. Based in
Taipei, we leverage the unique strengths of our thriving ecosystem to
position as the gateway to Asia for both local and international startups.
More information please refer to official facebook page:
https://www.facebook.com/tmubiomedaccelerator/posts/375002930661810
